Aventis Articles
FDA priority review for Sanofi's Lovenox in STEMI
12 February 2007
Sanofi appoints Tim Rothwell chairman of US unit
12 February 2007
Acomplia granted French reimbursement
12 February 2007
GSK's Arixtra gets FDA approvable letter
12 February 2007
AstraZeneca's R&D pipeline update reveals 120 NCEs and 25 LCM strategies in progress
12 February 2007
Thailand's "patent busting" goes ahead
7 February 2007
Stock Commentary - Europe - week to Jan 29, 2007
5 February 2007
Thailand's military govt breaks two patents
5 February 2007
Update: Rumors say Sanofi to merge with B-MS
5 February 2007
B-MS swings to loss in 4th qtr due to Plavix
5 February 2007
Rumors say Sanofi to merge with B-MS
5 February 2007
Pentacel gets FDA OK for pediatric use
5 February 2007
Appointments at Sanofi-Aventis UK
29 January 2007
Stock Commentary - Europe - week to Aug 15
29 January 2007
Japan stock market week to Jan 22, 2007
29 January 2007
France's Afssaps to review four drugs
29 January 2007
Ph III prasugrel trial completes enrollment
29 January 2007
Gardasil could slash cervical cancer 78%
29 January 2007
Sanofi goes to law in Germany on Acomplia
22 January 2007
R&D promotions at Sanofi-Aventis
15 January 2007
Stock Commentary - Europe - week to Jan 8, 2007
15 January 2007
Patent expiry will "constrain" antibacterial market
15 January 2007
Analysts see 2007 as key for ReGen Thera
15 January 2007
EFPIA Japan elects new board members
15 January 2007
World's "10 most promising" treatments
15 January 2007
Good patent news for Lilly, Pfizer and Sanofi-Aventis
8 January 2007
Sanofi board confirms Le Fur as CEO
8 January 2007
Sanofi chief savages third world generics
8 January 2007
French antibiotics consumption falls
8 January 2007
Strong data for Sanofi's Taxotere in node (+) breast cancer
22 December 2006
Sanofi Pasteur tops flu vaccine production
22 December 2006
Galapagos to buy ProSkelia for $16.5M
22 December 2006
MediGene signs mTCR R&D deal with Sanofi Pasteur
22 December 2006
FDA pulls Ketek from AECB and ABS market
22 December 2006
Herceptin/Taxotere improve DF survival
22 December 2006
Call for rapid worldwide access to new cervical cancer vaccines
22 December 2006
US Court upholds Sanofi and B-MS' injunction against Apotex
18 December 2006
Stock Commentary - Europe - week to Dec 11, 2006
18 December 2006
Sanofi-Aventis' enoxaparin cuts VTE risk 43%
18 December 2006
Sanofi's obesity drug Acomplia works against diabetes
18 December 2006
S-P's Aeris less side effects than Xyzal
11 December 2006
Pfizer drops star drug candidate after DSMB points out excessive mortality in Ph III trial
11 December 2006
Stock Commentary - Europe - week to December 4
11 December 2006
Novexel licenses aminocandin from Indevus
11 December 2006
Pfizer increases 2006 earnings forecast
11 December 2006
ING Parcom acquires Unither
4 December 2006
Stock Commentary - Europe - week to Nov 27
4 December 2006
Sanofi Pasteur meets US flu vacc delivery target, promises more
4 December 2006
Sanofi-Aventis expected to go for continuity in R&D
27 November 2006
US DHHS orders additional flu vaccine as pandemic precaution
27 November 2006
Stock Commentary - Europe - week to Nov 20, 2006
27 November 2006
Japan's generic drugs market expected to grow 8.8% from 2006 to 2008
27 November 2006
New Republican "hold" on FDA Commissioner
27 November 2006
S-A's Ketek under investigation by FDA over liver safety
20 November 2006
Sanofi, Innogenetics and Inserm in AD R&D deal
20 November 2006
EC plan on neglected diseases criticised
20 November 2006
Sanofi-Aventis gets EMEA ok for Taxotere in SCHN
13 November 2006
Stock Commentary - Europe - week to Nov 6, 2006
13 November 2006
Sanofi's Acomplia launched in Ireland
6 November 2006
Michel Labie takes over as head of Sanofi-Aventis communications
6 November 2006
Stock Commentary - Europe - week to Oct 30, 2006
6 November 2006
B-MS/Sanofi face Plavix injury law suits
6 November 2006
Anti-addiction therapies market 2006-11 - Pharma's next Viagra?
6 November 2006
Sanofi's Acomplia helps obese diabetics
6 November 2006
Generics, including Plavix, and govt cost-cutting hit Sanofi-Aventis' 3rd-qtr results
6 November 2006
Analysts view pharma revenue exposure in Japan
6 November 2006
Stock Commentary - Europe - week to Oct 23, 2006
30 October 2006
Pfizer's celecoxib to become Japan's first COX-2 inhibitor
30 October 2006
LibraGen and Sanofi-Aventis sign collaboration accord
30 October 2006
Sanofi's Acomplia hits buffers in Germany
30 October 2006
Sanofi Pasteur MSD's Gardasil beating GSK's Cervarix in race to dominate HPV vacc market
30 October 2006
Sanofi Pasteur's H5N1 vacc shows broad anti-infective properties
23 October 2006
Sanofi in-licenses ImmunoGen technology
23 October 2006
Sanofi-Aventis sells Rhodia stake for $229M
23 October 2006
Sanofi denies making $3B bid for ImClone
23 October 2006
Sanofi-Aventis "on track" in Hungary
23 October 2006
WHO and Sanofi-Aventis extend tropical disease program
16 October 2006
Job loss threat due to French drug price cuts
16 October 2006
GSK's Arixtra gets fast tracked by US FDA
16 October 2006
Servier to build Russian Rx plant
9 October 2006
Sanofi and UCB enter US co-promotion deal for Xyzal
2 October 2006
Russia's drug market surges on new state plan
2 October 2006
UK's NICE OKs Sanofi's Taxotere
2 October 2006
Apotex' denied motion to restart Plavix sales
2 October 2006
Ranbaxy's generic furosemide cleared in USA
25 September 2006
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
